| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
2019 ASH Annual Meeting
|
Yaqub, Farhat
|
|
|
7 |
1 |
p. e12-e13
|
artikel
|
| 2 |
Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states
|
Gondek, Lukasz P
|
|
|
7 |
1 |
p. e73-e81
|
artikel
|
| 3 |
Can paediatricians move directly to direct oral anticoagulants?
|
O'Brien, Sarah H
|
|
|
7 |
1 |
p. e2-e3
|
artikel
|
| 4 |
Correction to Lancet Haematol 2019; 6: e385–86
|
|
|
|
7 |
1 |
p. e11
|
artikel
|
| 5 |
Correction to Lancet Haematol 2019; 6: e398–408
|
|
|
|
7 |
1 |
p. e11
|
artikel
|
| 6 |
Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement
|
Mahadeo, Kris M
|
|
|
7 |
1 |
p. e61-e72
|
artikel
|
| 7 |
Diversity and Inclusion in Haematology
|
Marshall, Ariela
|
|
|
7 |
1 |
p. e14
|
artikel
|
| 8 |
Eligibility criteria in haematological cancer clinical trials—what's needed?
|
Calissano, Mattia
|
|
|
7 |
1 |
p. e10
|
artikel
|
| 9 |
Gita Thanarajasingam: making treatment more tolerable
|
Davies, Rachael
|
|
|
7 |
1 |
p. e17
|
artikel
|
| 10 |
GVHD risk assessment beyond current HLA evaluation
|
Paczesny, Sophie
|
|
|
7 |
1 |
p. e8-e9
|
artikel
|
| 11 |
Proliferation and differentiation
|
The Lancet Haematology,
|
|
|
7 |
1 |
p. e1
|
artikel
|
| 12 |
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial
|
Male, Christoph
|
|
|
7 |
1 |
p. e18-e27
|
artikel
|
| 13 |
Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study
|
Petersdorf, Effie W
|
|
|
7 |
1 |
p. e50-e60
|
artikel
|
| 14 |
Should high-risk smouldering multiple myeloma be treated?
|
Richard, Shambavi
|
|
|
7 |
1 |
p. e15-e16
|
artikel
|
| 15 |
Treosulfan-based or busulfan-based conditioning for allogeneic transplantation: the role of dose intensity
|
Shimoni, Avichai
|
|
|
7 |
1 |
p. e4-e5
|
artikel
|
| 16 |
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial
|
Beelen, Dietrich Wilhelm
|
|
|
7 |
1 |
p. e28-e39
|
artikel
|
| 17 |
Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial
|
Notten, Pascale
|
|
|
7 |
1 |
p. e40-e49
|
artikel
|
| 18 |
Using it wisely: catheter-directed thrombolysis for deep vein thrombosis
|
Vedantham, Suresh
|
|
|
7 |
1 |
p. e6-e7
|
artikel
|
Tijdschrift beschrijving